An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus

PHASE2TerminatedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

January 9, 2018

Primary Completion Date

November 20, 2019

Study Completion Date

November 20, 2019

Conditions
Lupus Erythematosus, Systemic
Interventions
DRUG

GDC-0853

Participants received GDC-0853 at a dose of 200mg, as per the dosing schedule described above.

Trial Locations (53)

1000

Medical Center Excelsior OOD, Sofia

1431

"UMHAT Sv. Ivan Rilski, EAD", Sofia

1784

"MC Synexus - Sofia, EOOD", Sofia

1900

Hospital Italiano de La Plata, La Plata

4003

MHAT Plovdiv, Plovdiv

5400

CER San Juan Centro Polivalente de Asistencia e Investigacion Clinica, San Juan

6000

"Medical Center Nov Rehabilitatsionen Tsentar, EOOD", Stara Zagora

7000

"Medical Center Teodora, EOOD", Rousse

10002

National Taiwan University Hospital, Taipei

15006

Fundación Profesor Novoa Santos, A Coruña

25000

Hospital Universitario de Saltillo, Saltillo

27000

Centro de Investigacion Alberto Bazzoni S.A. de C.V., Torreón

27617

Shanahan Rheumatology & Immunology, PLLC, Raleigh

28007

Hospital General Universitario Gregorio Marañon, Madrid

33486

RASF-Clinical Research Center, Boca Raton

33511

Bay Area Arthritis and Osteoporosis, Brandon

33765

Clinical Research of West Florida, Clearwater

47005

Hospital Clinico Universitario Valladolid, Valladolid

47012

Hospital Universitario Rio Hortega, Valladolid

66901

Dermacross, Santiago

70809

Ochsner Clinic Foundation, Baton Rouge

77089

Accurate Clinical Research, Houston

78240

Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosi S.l.p.

78666

Arthritis Clinic Of Central Texas, San Marcos

78745

Tekton Research Inc, Austin

80020

Centro de Investigacion Medico Asistencial S.A.S, Barranquilla

83404

Institute of Arthritis Research, Idaho Falls

90720

Valerius Medical Group, Los Alamitos

97000

Unidad de Atencion Medica e Investigacion en Salud S.C., Mérida

680003

Medicity S.A.S., Bucaramanga

Servimed S.A.S., Bucaramanga

7500571

CTR Estudios SPA, Providencia

7501126

Centro de Estudios Reumatologi, Santiago

00833

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

SE1 9RT

Guy's Hospital; Louise Coote Lupus Unit, London

77058-3675

Accurate Clinical Research, Houston

C1194AAO

APRILLUS, Buenos Aires

T4000AXL

Centro Médico Privado de Reumatología, San Miguel de Tucumán

74110-120

CIP - Centro Internacional de Pesquisa, Goiânia

36036-330

Centro Mineiro de Pesquisa - CMIP, Juiz de Fora

80440-080

Edumed - Educação e Saúde SA, Curitiba

90035-170

Centro de Pesquisas em Diabetes - CPD, Porto Alegre

88301-220

Clinica de Neoplasias Litoral, Itajaí

09060-650

Faculdade de Medicina do ABC - FMABC, Santo André

09190-510

Centro Multidisciplinar de Estudos Clínicos - CEMEC*X*, Santo André

01228-200

Centro de Pesquisas Clinicas; CPCLIN, São Paulo

04023-000

Hospital Abreu Sodré - AACD, São Paulo

Unknown

Biomedica, Santiago

00000

Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS, Barranquilla

050034

Hospital Pablo Tobon Uribe, Medellín

07760

Hospital Angeles Lindavista, México

05030

Konkuk University Medical Center, Seoul

08035

Hospital Universitari Vall d'Hebron, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY